Description

Ibandronate is a bisphosphonate medication used primarily to treat osteoporosis in postmenopausal women and to prevent bone complications in patients with certain types of cancer. It works by inhibiting bone resorption, thereby increasing bone density and reducing the risk of fractures.

Interpreter Notes

Interpreters should be aware that 'Ibandronato' is the standard term used in clinical contexts. Colloquial variants may include 'ibandronato sódico', which should be avoided in formal settings. It's important to maintain a formal register when discussing medications.

Example Sentences

EN: The doctor prescribed Ibandronate to help strengthen the patient's bones.

ES: El médico recetó Ibandronato para ayudar a fortalecer los huesos del paciente.

Common Interpreter Mistakes

Confusing Ibandronate with similar-sounding medications like Alendronate; mixing up the terms for osteoporosis treatments; mispronouncing 'Ibandronato' as 'Ibandronato sódico' when referring to the medication.